NUVATION BIO INC (NUVB) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:NUVB - US67080N1019 - Common Stock
8.55 USD
+0.24 (+2.89%)
8.46 USD
-0.09 (-1.05%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.873M | 55.863M 609.55% | 166.42M 197.91% | 287.17M 72.56% | 491.25M 71.07% | 558.49M 13.69% | 755.35M 35.25% | 1.03B 36.36% | 1.345B 30.58% | |||
| EBITDA YoY % growth | -112.13M -20.39% | -99.6M 11.17% | -166.874M -67.54% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -112.33M -20.37% | -99.822M 11.14% | -167.557M -67.86% | -223.916M -33.64% | -171.034M 23.62% | -88.469M 48.27% | 42.32M 147.84% | 54.949M 29.84% | 206.44M 275.69% | 404.7M 96.04% | 609.9M 50.70% | |
| Operating Margin | N/A | N/A | -2,128.25% | -400.83% | -102.77% | -30.81% | 8.61% | 9.84% | 27.33% | 39.29% | 45.35% | |
| EPS YoY % growth | -0.48 -9.09% | -0.34 29.17% | -0.52 -52.94% | -0.60 -16.28% | -0.52 13.46% | -0.23 55.17% | 0.85 460.87% | 3.43 304.82% | -0.23 -106.85% | 0.17 173.91% | 0.59 241.18% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 30.91% | -0.19 -18.05% | -0.17 0.80% | -0.12 25.94% | -0.14 -34.52% | -0.15 21.69% | -0.15 8.67% | -0.12 1.87% | -0.03 78.78% | -0.03 80.00% | -0.03 78.81% |
| Revenue Q2Q % growth | 33.564M 487.71% | 29.213M 847.24% | 37.658M 679.18% | 45.792M 249.02% | 42.362M 26.21% | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -41.6M 22.88% | -47.783M 19.02% | -45.503M 28.44% | -43.143M 23.55% | -31.595M 24.05% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.16 -6.67% | -0.17 | 0.01 | 6.98% |
| Q2 2025 Q2Q % growth | -0.17 -13.33% | -0.17 | 0.00 | 0.88% |
| Q1 2025 Q2Q % growth | -0.16 -128.57% | -0.16 | 0.00 | 0.90% |
| Q4 2024 Q2Q % growth | -0.15 -150.00% | -0.14 | -0.01 | -6.56% |
| Q3 2024 Q2Q % growth | -0.15 -66.67% | -0.13 | -0.02 | -13.12% |
| Q2 2024 Q2Q % growth | -0.15 -66.67% | -0.06 | -0.09 | -151.38% |
| Q1 2024 Q2Q % growth | -0.07 30.00% | -0.10 | 0.03 | 28.36% |
| Q4 2023 Q2Q % growth | -0.06 40.00% | -0.11 | 0.05 | 43.89% |
| Q3 2023 Q2Q % growth | -0.09 25.00% | -0.11 | 0.02 | 19.54% |
| Q2 2023 Q2Q % growth | -0.09 43.75% | -0.11 | 0.02 | 21.10% |
| Q1 2023 Q2Q % growth | -0.10 | -0.10 | 0.00 | 1.96% |
| Q4 2022 Q2Q % growth | -0.10 16.67% | -0.12 | 0.02 | 14.75% |
| Q3 2022 Q2Q % growth | -0.12 -9.09% | -0.14 | 0.02 | 15.97% |
| Q2 2022 Q2Q % growth | -0.16 -77.78% | -0.14 | -0.02 | -18.07% |
| Q1 2022 Q2Q % growth | -0.10 16.67% | -0.15 | 0.05 | 31.92% |
| Q4 2021 Q2Q % growth | -0.12 -152.08% | -0.12 | 0.00 | 0.58% |
| Q3 2021 Q2Q % growth | -0.11 | -0.11 | 0.00 | -1.74% |
| Q2 2021 Q2Q % growth | -0.09 | -0.10 | 0.01 | 9.96% |
| Q1 2021 Q2Q % growth | -0.12 | -0.07 | -0.05 | -68.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 13.12M 1,704.68% | 6.746M | 6.374M | 94.49% |
| Q2 2025 Q2Q % growth | 4.833M 236.79% | 364.283K | 4.469M | 1,226.72% |
| Q1 2025 Q2Q % growth | 3.084M | 425.003K | 2.659M | 625.64% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.11% | 29.93% | 9.27% | 8.5% |
| Revenue | 10.38% | 83.66% | 85.18% | 63.95% |